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Electrocardiography
Importance
Electrocardiography is the most commonly used diagnostic
test in cardiology. Properly interpreted, it contributes sig-
nificantly to the diagnosis and management of patients with
cardiac disorders. Importantly, it is essential to the diagnosis
of cardiac arrhythmias and the acute myocardial ischemic
syndromes. These 2 conditions account for the majority of
cardiac catastrophes. It is appropriately used as a screening
test in many circumstances.
Goal of Training
Although every physician should have a basic knowledge of
electrocardiography, and the general internist should have
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more advanced knowledge than most others, the subspecial-
ist in cardiology should be familiar with nearly all clinically
encountered patterns of depolarization and repolarization
and of arrhythmias. The trainee should understand clinical
implications, sensitivity, and specificity of the test, and
should be able to identify normal variants. The trainee
should have sufficient basic knowledge to understand the
physiologic mechanisms for arrhythmias and electrocardio-
graphic waveforms rather than to simply recognize patterns.
The recognition and understanding of the basis for the
items included in Appendix 1 of this task force report are
minimum requirements for each trainee.
The trainee should also be familiar with the instrumen-
tation necessary to acquire, process, and store electrocardio-
grams (ECGs), in both analog and digital format. The
trainee should understand the effect of acquisition rates and
filter settings, as well as recognize electronic artifacts. The
trainee should be able to accurately measure basic ECG
intervals in both analog and digital systems.
Training
An essential feature of training is to interpret a large number
of ECGs and to review all interpretations with experienced
faculty. The committee recommends that all trainees
achieve Level 2 training in ECG interpretation. This
necessitates interpreting 3500 ECGs over 24 to 36 months
(Table 1). These should be documented individually. This
may be accomplished by 1 or more training periods assigned
specifically for interpretation of ECGs, or it may be an
experience provided in a continuing manner. The experi-
ence should include clinical correlation in patients in inten-
sive care units, emergency rooms, and pacemaker/
defibrillation clinics. The ECG should be integrated with
the clinical problem. Formal courses and correlative confer-
ences in electrocardiography are strongly recommended. In
addition, guidelines for the role of electrocardiography in
clinical practice should be thoroughly understood, reviewed,
and followed (1).
In-Training Evaluation
The trainee must become familiar with the indications for
electrocardiography and electrophysiologic studies. Simi-
larly, the trainee should be familiar with the principles of
intracardiac electrophysiologic studies, their indications,
contraindications, sensitivity, and specificity (see the Task
Force 6 report). The trainee should be evaluated on an
ongoing basis by responsible faculty to determine that the
trainee has integrated these knowledge bases. Because of
variability in training in electrocardiography and to doc-
ument the trainee’s proficiency, an in-training examina-
tion in electrocardiography should be used and imple-
mented by each training program. The Adult Clinical
Cardiology Self-Assessment Program (ACCSAP) con-
tains a self-assessment examination in electrocardiogra-
phy, which is available on a national basis and is useful for
identifying knowledge areas of specific weakness and
levels of proficiency.
Ambulatory ECG Monitoring
Importance
Observation and documentation of cardiac rhythm during
daily activities, as well as the relation of the rhythm
disturbances to patient symptoms, are important factors for
clinical decision making. Major indications for ambulatory
ECG monitoring include the following: detection of or
ruling out of rhythm disturbances as a cause of symptoms;
detection and assessment of arrhythmias believed to be
associated with an increased risk for cardiovascular events;
the identification and accurate interpretation of ambulatory
ST-T wave changes occurring throughout a diurnal time
period; assessment of efficacy of antiarrhythmic and anti-
ischemic therapy; and investigation of the effects of therapeutic
devices (e.g., pacemakers and implantable cardioverter-
defibrillator).
Summary of Training Requirements in Electrocardiography, Ambulatory Electrocardiography, and Exercise Testing
Table 1 Summary of Training Requirements in Electrocardiography, Ambulatory Electrocardiography, and Exercise Testing
Task
Force Area Level
Minimal Number of
Procedures
Cumulative Duration
of Training (Months)
Minimal Cumulative Number
of Cases Comments
2 Electrocardiography 1 3500*† 3500 *Can be taken throughout the
training program.
†The committee strongly
recommends that
cardiologists achieve Level
2 training in ECG
interpretation.
2 3500 36
Ambulatory monitoring 1 150* 150 *Can be taken throughout the
training program.
2 75 225
Exercise testing 1 200* 200 *Can be taken throughout the
training program.
2 100 300
ECG  electrocardiogram.
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Goal of Training
The technology is not perfect, and multiple methods of
recording and analysis are currently in use. The trainee
should understand the differences between continuous and
intermittent recordings and the advantages and disadvan-
tages of each and should have a basic knowledge of the
various methods used for arrhythmia and ST-segment
detection, classification, and analysis. The trainee should
understand the potential pitfalls inherent in each method.
In addition, the trainee should have current knowledge
about what may represent a “normal” finding for various age
groups during sleeping and waking hours and what should
be considered “abnormal,” realizing that the clinical signif-
icance of some findings on ambulatory monitoring is still
unresolved.
Structure of Training
The trainee should participate in interpretation sessions
with a staff cardiologist knowledgeable in the indications for
the test, the techniques of recording, and the clinical
significance and correlations of findings. It is recommended
that the trainee interpret a minimum of 150 ambulatory
ECG recordings over 24 to 36 months. Ideally, the trainee
should be exposed to both full-disclosure (complete print-
out) and computer-assisted systems so that the advantages,
disadvantages, and cost of each may be understood. In
addition, transtelephonic and event-recorder devices are
increasingly used on an adjunct basis for prolonged ambu-
latory electrocardiography. Knowledge of their indications
and limitations must also be gained, preferably from struc-
tured training in ambulatory electrocardiography that per-
mits interaction of the trainee with an experienced cardio-
vascular technician and ambulatory ECG instrumentation
and review of interpreted records with the attending cardi-
ologist with specific expertise in ambulatory electrocardiog-
raphy. Such training will provide knowledge to satisfy
clinical competence in ambulatory electrocardiography as
indicated by the American College of Cardiology (ACC)/
American Heart Association (AHA)/American College of
Physicians–American Society of Internal Medicine (ACP–
ASIN) Task Force on Clinical Competence (1).
Level 2 trainees will interpret a minimum of 75 additional
recordings over 12 months (a total of 225 recordings over 36
months). Such recordings or other provided material should
include all forms of artifact, pacemaker, and implantable
cardioverter-defibrillator patterns, heart rate variability
studies, repolarization abnormalities (e.g., QT or T wave
alternans), and applications of the signal-averaged ECG.
Such trainees will demonstrate knowledge of the operation
and limitations of a variety of types of ambulatory ECG
instrumentation. Additional ECG interpretation of in-
hospital telemetry ECGs is required. This may range from
6 to 8 s of real-time printout strips to 72 h of full-disclosure
data. Such ECG data often augment standard and ambu-
latory electrocardiography. Trainees will be experienced in
the interpretation and limitations, since knowledge at this
level also supports the objectives of Level 2 training in
electrophysiology, pacing, and arrhythmia management (see
the Task Force 6 report).
In-Training Evaluation
Because of the large number of different rhythm patterns
seen during routine clinical ambulatory ECG recordings
and the many technologic approaches, it may not be possible
to assess adequately a trainee’s expertise in ambulatory
electrocardiography by a uniform, written examination.
Thus, the trainee must be given the responsibility for initial
interpretation of all phases of the ambulatory ECG study.
The trainee should provide a detailed interpretation and
review it with the attending cardiologist responsible and
experienced in ambulatory electrocardiography. This at-
tending cardiologist is responsible for the evaluation and
documentation of a trainee’s progress and skills.
Evolving New Applications
Long-term ambulatory electrocardiography continues to
evolve with regard to QT measurements and heart rate
variability studies. These measurements provide insight into
ventricular repolarization changes and the autonomic ner-
vous system (sympathetic and parasympathetic) over ex-
tended periods of ambulatory electrocardiography. Trainees
should be cognizant of these developments and follow their
evolution and clinical application.
Exercise Testing
Importance
Exercise testing is an important physiologic procedure used
to elicit cardiovascular abnormalities not present at rest and
to determine adequacy of cardiac function. These tests are
valuable clinical procedures used to assess patients with
suspected or proven cardiovascular disease. Exercise testing
is used primarily to estimate prognosis, determine func-
tional capacity, provide a diagnostic estimate of the likeli-
hood and extent of coronary disease, and determine the
effects of therapy. Exercise electrocardiography is also com-
bined with ancillary techniques such as radionuclide imag-
ing, echocardiography, or metabolic gas analysis to enhance
the information content of the test in selected patients.
Goal of Training
The trainee should become proficient at performing both
heart rate-limited and maximal or near-maximal treadmill
exercise tests and should have the opportunity to learn
alternative exercise testing techniques. The training pro-
gram should provide the opportunity for the trainee to
become knowledgeable in exercise physiology and patho-
physiology. The trainee should also be taught the essentials
of exercise testing, such as skin preparation, electrode
selection and application, choice of exercise testing proto-
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cols, blood pressure monitoring during exercise, and mon-
itoring of the patient for adverse signs or symptoms. The
trainee should be thoroughly familiar with evidence-based
indications and contraindications to exercise testing. The
trainee must become proficient in the interpretation of
commonly used measurements available from the exercise
test. These include the onset and offset of ischemic ST-
segment depression and the distinction between normal
variants and abnormal patterns, exercise-induced cardiac
arrhythmias, magnitude and slope of ST-segment depres-
sion or elevation, ST/heart rate indexes, exertional hypo-
tension, chronotropic incompetence, heart rate recovery,
and hemodynamic measurements such as maximum exercise
heart rate, systolic blood pressure, and double product. The
trainee should become proficient in integrating the data,
understanding the reasons for stopping exercise, and estab-
lishing diagnostic accuracy (sensitivity and specificity) and
prognostic importance of the procedure in different clinical
settings as described in the ACC/AHA guidelines for
exercise testing (2). This training will provide knowledge to
satisfy clinical competence in exercise testing, as indicated
by the ACC/AHA/ACP–ASIN Task Force on Clinical
Competence.
Structure of Training and In-Training Evaluation
The training of a fellow in cardiology should include at least
2 months, or the equivalent, of active participation in a fully
equipped exercise testing laboratory, during which time the
fellow should perform a minimum of 200 exercise tests
reviewed by faculty. This experience can be obtained con-
currently with training in an exercise imaging laboratory as
part of the training requirements in nuclear cardiology or
echocardiography. Level 1 trainees will gain proficiency in
the standard exercise test and its interpretation (minimum
experience 200 tests), to include pharmacologic testing
(dipyridamole, adenosine, and dobutamine), whereas Level
2 trainees (additional 100 tests) will become experienced in
advanced forms of exercise testing, which include arrhyth-
mia evaluation, ventilatory gas studies, pulmonary function
testing as part of cardiopulmonary stress testing, stress
echocardiographic techniques, and nuclear cardiology (see
the Task Force 4 and 5 reports).
The laboratory should be engaged in the performance of
exercise tests on a regular basis that involve a broad
spectrum of both inpatients and outpatients with a variety of
known and suspected cardiac disorders. The training pro-
gram should be structured so that the trainee is guided in
the laboratory by a specially trained exercise professional
until the trainee has become proficient at conducting and
monitoring exercise tests under a variety of clinical circum-
stances. The trainee must be given the responsibility for
initial interpretation of all phases of the exercise study,
providing a detailed interpretation, and reviewing it with
the attending cardiologist responsible and experienced in
exercise testing. The faculty physician should assess and
document the trainee’s progress on a regular basis, including
technical performance and ability to interpret results.
This is a revision of the 2002 document that was written by
Robert J. Myerburg, MD, FACC—Chair; Bernard R. Chait-
man, MD, FACC; Gordon A. Ewy, MD, FACC; and Melvin
M. Scheinman, MD, FACC.
doi:10.1016/j.jacc.2007.11.010
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APPENDIX 1: ELECTROCARDIOGRAPHIC KNOWLEDGE BASE AND
INTERPRETATION
Anatomy and Electrophysiology
1. Anatomy of the specialized conducting system (sino-
atrial node, atrioventricular node, His bundle, bundle
branches), concept of the trifascicular conduction
system
2. Spread of excitation in the ventricles
3. Difference between unipolar and bipolar leads
4. Einthoven triangle; frontal and horizontal lead refer-
ence system
5. Vectorial concepts
6. Significance of a positive and negative deflection in
relation to lead axis
7. Relation between electrical and mechanical activity
Technique and the Normal ECG
8. Effect of improper electrode placement (limb and
precordial)
9. Effect of muscle tremor
10. Effect of poor frequency response of the equipment
11. Effect of uneven paper transport
12. Measurement of PR, QRS, QT, normal values/rate
correction of QT interval
13. Normal ranges of axis in the frontal plane
14. Effect of age, weight, and body build on the axis in
the frontal plane, as well as specific ECG diagnoses
(i.e., left ventricular hypertrophy, left ventricular hy-
pertrophy, and strain)
15. Normal QRS/T angle
351JACC Vol. 51, No. 3, 2008 Myerburg et al.
January 22, 2008:348–54 ACCF COCATS 3 Training Statement: Task Force 2
16. Differential diagnosis of normal ST-T, T-wave vari-
ants (e.g., “juvenile” pattern and early repolarization
syndrome)
Arrhythmias: General Concepts
17. Reentry, automaticity, triggered activity
18. Aberration (various mechanisms)
19. Capture and fusion complexes
20. Escape (passive, accelerated) complexes or rhythms:
atrial, junctional, and ventricular
21. Interpolated premature beat
22. Parasystole (atrial, junctional, ventricular), modulated
parasystole
23. Vulnerability
24. Exit block
25. Reciprocation
26. Concealed conduction
27. Supernormality
Arrhythmias: Recognition
Sinoatrial Rhythm
28. Sinus tachycardia
29. Sinus bradycardia
30. Sinus arrhythmia
31. Sinoatrial arrest
32. Sinoatrial block
Atrial Rhythms
33. Atrial premature complexes (conducted, noncon-
ducted)
34. Atrial tachycardia (ectopic)
35. Atrial tachycardia with atrioventricular block
36. Atrial fibrillation
37. Atrial flutter (typical and atypical forms)
38. Multifocal atrial tachycardia
39. Wandering atrial pacemaker-multifocal atrial rhythm
Atrioventricular Node (Junctional)
40. Premature junctional complexes
41. Atrioventricular node re-entrant tachycardia (com-
mon and uncommon type)
42. Nonparoxysmal junctional tachycardia-accelerated
junctional rhythm
43. Atrioventricular re-entrant or circus movement
tachycardia with an accessory pathway
44. Escape complex or escape rhythm
Ventricular
45. Ventricular ectopic complexes
46. Accelerated idioventricular rhythm
47. Ventricular tachycardia: uniform (monomorphic),
multiform (pleomorphic or polymorphic), sustained,
nonsustained, bidirectional, and torsades de pointes
48. Ventricular flutter, ventricular fibrillation
49. Ventriculoatrial conduction
50. Ventricular escape or idioventricular rhythm
Atrioventricular Dissociation Due To:
51. Slowing of dominant pacemaker
52. Acceleration of subsidiary pacemaker
53. Above with depression of atrioventricular conduction
54. Third-degree atrioventricular block
55. Isorhythmic atrioventricular dissociation
Atrioventricular Block
56. First degree
57. Second degree; 2:1, Mobitz type I (Wenckebach),
Mobitz type II, high-degree atrioventricular block
58. Third-degree atrioventricular block (complete)
59. Significance of wide versus normal QRS complex
Waveform Abnormality
Abnormalities of Repolarization (Concept of Primary and
Secondary ST-T Wave Change); Abnormalities of U Wave;
Ventricular Hypertrophy
60. Left ventricular hypertrophy: criteria for left ventric-
ular hypertrophy; specificity and sensitivity of criteria
61. Right ventricular hypertrophy: criteria for right ven-
tricular hypertrophy; sensitivity and specificity of the
criteria
62. Biventricular hypertrophy
63. Electrical alternans
Atrial Abnormalities
64. Criteria for left atrial abnormality
65. Criteria for right atrial abnormality
66. Biatrial abnormality
67. Clinical significance of atrial abnormalities
Intraventricular Conduction Disturbances
68. Anatomic and electrophysiologic basis for intraven-
tricular conduction defects
69. Criteria for incomplete and complete left bundle-
branch block
70. Criteria for the diagnosis of incomplete and complete
right bundle-branch block
71. Criteria for left anterior and posterior fascicular blocks
72. Concept of combined bundle and fascicular blocks
73. Indeterminate intraventricular conduction defects
74. Diagnosis and classification of pre-excitation syn-
dromes (e.g., Wolff-Parkinson-White syndrome)
Myocardial Ischemia and Infarction
75. Transient ischemia and injury
76. Normal Q waves
77. Abnormal Q waves not associated with infarction
78. Differential diagnosis of tall R wave in right precor-
dial leads
79. Theoretical basis of ECG changes in acute myocar-
dial infarction (Q, ST-T waves)
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80. Time course of ST-segment changes in acute myo-
cardial infarction
81. Diagnosis of myocardial infarction (without Q waves)
82. ST-segment changes in conditions other than myo-
cardial infarction
83. Localization of myocardial infarction
84. QRS residuals of old myocardial infarction
85. Reliability of QRS and ST-segment changes of myo-
cardial infarction in previously abnormal ECG: intra-
ventricular conduction defects; ventricular hypertrophy
86. Overall assessment of serial ECGs as to the proba-
bility of acute myocardial infarction
Pacemaker
87. Fixed-rate pacemaker
88. Atrial pacing
89. Ventricular demand pacing
90. Atrial triggered ventricular pacing
91. Atrioventricular dual pacing
92. Malfunctioning: demand acting as fixed rate; failure
to sense; slowing of rate; acceleration of rate; failure
to capture; failure to pace (inappropriate inhibition)
Exercise ECG Test
93. Criteria for a positive response
94. Significance of an abnormal baseline ECG; effect of
drugs; effect of pre-excitation
95. Significance of heart rate and blood pressure response
(normal and abnormal)
96. Sensitivity: false-negative (incidence and principal
causes)
97. Specificity: false-positive (incidence and principal
causes)
98. Significance of magnitude of ST-segment changes
99. Normal responses to maximum exercise testing
100. Exercise-induced rapid versus slow upsloping ST-
segment depression
101. Exercise-induced minor versus abnormal horizontal
or downsloping ST-segment depression
102. Exercise-induced ST-segment elevation in noninfarct-
related versus infarct-related leads
103. Exercise-induced intraventricular conduction dis-
turbance
104. Exercise-induced ventricular and supraventricular
arrhythmias
105. Exercise-induced hypertensive or hypotensive
response
106. Sensitivity, specificity, and predictive accuracy in
clinical patient subsets
107. Identification of chronotropic incompetence or accel-
erated ventricular response
108. Utility of peak exercise capacity, ECG, hemodynamic
response, and exercise-induced symptoms
109. Noncoronary causes of exercise-induced ST-segment
depression
110. Exercise parameters that indicate adverse prognosis or
multivessel coronary disease
111. Indications and contraindications for exercise testing
112. Exercise testing with ventilatory gas analysis
113. Exercise testing in special groups: women, asymp-
tomatic subjects, post-revascularization patients,
post-myocardial infarction or acute coronary syn-
drome patients
114. Evaluation of valvular heart disease
115. Evaluation of cardiac arrhythmias
116. Interpretation of exercise test results in subjects with
resting ST-segment depression, left ventricular hy-
pertrophy, Wolff-Parkinson-White syndrome, pace-
makers, or cardiomyopathy
Clinical Diagnoses (Selected)
117. Hyperkalemia
118. Hypokalemia
119. Hypercalcemia
120. Hypocalcemia
121. Long-QT syndromes (congenital and acquired)
122. Atrial septal defect, secundum
123. Atrial septal defect, primum
124. Dextrocardia
125. Mitral stenosis
126. Chronic obstructive pulmonary disease
127. Acute cor pulmonale
128. Pericardial effusion
129. Acute pericarditis
130. Hypertrophic cardiomyopathy
131. Central nervous system disorder
132. Myxedema
133. Hypothermia
134. Sick sinus syndrome
135. Digitalis effect or toxicity
136. Effects of other drugs (e.g., tricyclic or antiarrhythmic
agents)
137. Possible proarrhythmic effects
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